BNGO - Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual Meeting | Benzinga
- A sponsored session will feature Dr. Lucia Gallego Villarejo from Ruhr University Bochum, Dr. Jeanne Loring from Scripps Research Institute, and Dr. Alicia Bertolotti from Bionano presenting on the utility of optical genome mapping (OGM) across cell and gene therapy research, development and manufacturing applications
- Two scientific posters featuring results from OGM applications in cell manufacturing and bioprocessing applications will be presented at the conference
SAN DIEGO, July 02, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today announced its participation in the International Society for Stem Cell Research (ISSCR) Annual Meeting 2024 with a broad range of content covering the utility of optical genome mapping (OGM) for research, development, and manufacturing applications in stem cell therapy. ISSCR's annual meeting brings together industry, medical, and academic professionals to discuss advances in stem cell research and regenerative medicine. The ISSCR conference will be held July 10-13, 2024, in Hamburg, Germany.
As part of a sponsored session titled "High-resolution genome integrity assessment in stem cell therapy development with optical genome mapping," three experts will discuss the critical role of OGM in assessing the genome integrity and off-target events in engineered cells, specifically within the context of stem cell research. Presentations will cover OGM's utility for monitoring genomic integrity and off-target effects in cell lines and its potential to improve the quality, safety, and overall risk profile of next-generation therapy development and manufacturing. Dr. Lucia Gallego Villarejo from Ruhr University Bochum, Dr. Jeanne Loring from Scripps Research Institute, and Dr. Alicia Bertolotti from Bionano will present in Hall G2 on Friday, July 12, 2024, at 12:00 PM CEST.
Two scientific posters by Dr. Alex Hastie and Alex Chitsazan from Bionano, covering the use of OGM in cell manufacturing and bioprocessing applications, will be on display during the conference.
| Session |
| Title |
| Presenter |
| Presented |
| Innovation Session |
| High-resolution genome integrity assessment in stem cell therapy development with optical genome mapping |
| Gallego Villarejo L., Loring J., Bertolotti A. |
| July 12, 2024 ... |